Markets
Reddit listing day
(Reddit)

Reddit rips higher after crushing Q1 earnings estimates and offering upbeat guidance

Reddit’s blowout quarter had Wall Street smashing the upvote button.

Reddit shares soared more than 18% in after-hours trading after the social media company blew past earnings expectations and offered an upbeat outlook for the current quarter.

Earnings per share came in at $0.13, a huge beat versus the $0.02 analysts were expecting. Reddit’s revenue jumped 61% to $392 million, topping Wall Streets estimates as well as its own guidance of $360 million to $370 million.

Reddit has been riding a wave of user growth, boosted by changes to Google Search and its own internal site tweaks. Global logged-in daily active users jumped 23% to 48.7 million, while logged-out DAUs surged 38% to 59.4 million.

In regard to recent global trade tensions, the company said it was “well-positioned” to meet the moment. “We’ve grown through challenging times before — people need connection and information just as much in uncertain times,” Reddit CEO Steve Huffman said in a letter to investors.

Looking ahead, Reddit expects Q2 revenue between $410 million and $430 million, well ahead of Wall Street’s $391 million estimate.

More Markets

See all Markets
markets

Kenvue rises in early trading, reversing some of yesterday's drop, as scientists push back on Tylenol-autism link

Kenvue, the company behind pain-relief medication Tylenol, is seeing shares rebound a little this morning, as doctors push back against President Trump’s claims about the drug’s link to autism, per Reuters.

At a news conference yesterday, the president repeatedly warned pregnant women to avoid taking Tylenol, suggesting that the drug’s active ingredient (acetaminophen) is connected to rising autism rates in the US, sending shares in Kenvue, which was spun off from Johnson & Johnson just over two years ago, slumping to a record low.

A company spokesperson has since rejected the claims, scientists have started weighing in, and the FDA has confirmed that, while it will change warning labels on drugs containing acetaminophen, a causal relationship has not been established.

The company’s stock was up around 6% in premarket trading as of 6:20 am ET.

markets

Chinese EV maker Nio sinks as a surge of orders for its new SUV create a 6-month backlog

Shares of Nio are falling Monday on the bittersweet news that its latest SUV (the ES8, priced to compete with Tesla’s Model Y) is too popular.

According to Chinese media reports, up to 50,000 ES8 orders may have been placed in the vehicle’s first 36 hours, surpassing Nio’s 40,000-vehicle production cap for this year.

Customers now ordering the ES8 won’t receive their vehicle for 24 to 26 weeks, or six months.

Nio CEO William Li said that the ES8’s production capacity will reach 15,000 units by December.

Customers now ordering the ES8 won’t receive their vehicle for 24 to 26 weeks, or six months.

Nio CEO William Li said that the ES8’s production capacity will reach 15,000 units by December.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.